Deadliest Measles Outbreak in Years Kills 610 Children in Bangladesh

DHAKA, Bangladesh — A devastating, fast-moving measles outbreak has claimed the lives of at least 610 children in Bangladesh since mid-March, exposing dangerous gaps in the nation’s health safety net. According to the country’s Directorate General of Health Services (DGHS), the crisis has rapidly escalated, engulfing 58 out of 64 districts nationwide. With more than 62,000 pediatric hospitalizations and five additional children dying from measles-like symptoms within the last 24 hours alone, international aid agencies and domestic health authorities are racing to contain what has become the deadliest resurgence of the virus in recent memory.

Key Findings: The Staggering Scale of the Crisis

As of June 5, 2026, epidemiological data reveals a dual reality of skyrocketing suspected infections and strained diagnostic pipelines. The DGHS has officially logged:

• 76,876 suspected measles cases nationwide.

• 9,503 laboratory-confirmed infections.

• 62,287 hospitalizations since March 15, with 58,154 children listed as recovered.

Of the 610 reported fatalities, 91 are laboratory-confirmed measles deaths, while 519 are classified by health authorities as suspected measles deaths.

The case fatality rate (CFR) stands at an overall 0.83%—averaging 1.00% for confirmed cases and 0.70% for suspected cases. This translates to roughly 1 death per 120 infected children. According to data from the Centers for Disease Control and Prevention (CDC), this figure is drastically higher than the typical measles mortality rate of 1 to 3 deaths per 1,000 cases normally observed in well-nourished populations with stable access to healthcare.

Children Under Five Bear the Brunt

The epidemiological profile of the outbreak highlights an acute vulnerability among young children. Bangladesh Health Minister Sardar Shakhawat Hossain Bokul noted that 82% of all measles and rubella infections have occurred in children under five years of age. Public health datasets show that infants under nine months old—who are traditionally too young to receive their first routine dose of the measles-rubella (MR) vaccine—make up 34% of the total caseload.

Vaccination histories from this outbreak reveal staggering gaps in population immunity:

[Vaccination Status of Infected Children]
- Zero Vaccine Doses Received: 72%
- Partially Vaccinated (1 Dose): 16%

Public health analysts link this vulnerability to a multi-year decline in routine child immunizations. Between 2019 and 2024, coverage for the first dose of the measles-rubella vaccine (MR1) dropped from 88.6% to 86%, while the second dose (MR2) plummeted from 89% to 80.7%.

Expert Commentary: Disruptions and Pathogen Dynamics

Public health experts emphasize that the current crisis is a predictable consequence of accumulated immunity gaps, exacerbated by recent socio-political disruptions.

“The outbreak’s scale and rapid spread are driven by structural immunity gaps, high population mobility during recent festive seasons, and vaccine supply constraints,” said Dr. Vinod Bura, Regional Advisor for the World Health Organization (WHO) Southeast Asia Office. “This combination risks prolonging active transmission and severely straining local health infrastructure.”

Virologists monitoring the crisis have identified the primary pathogen as the B3 strain of the measles virus. While this older variant has been the predominant strain circulating in the region for years, it has turned lethal due to the sheer volume of unprotected hosts.

Health experts point out that the political transition to the Tarique Rahman government earlier this year inherited a fragile public health system. Bangladesh’s last comprehensive nationwide measles campaign took place in 2020. A follow-up drive scheduled for 2024 was shelved due to widespread civil unrest, allowing a critical mass of unvaccinated children to accumulate.

Why the Outbreak Turned So Deadly

Measles is an exceptionally contagious airborne virus with a basic reproduction number ($R_0$) often cited between 12 and 18, meaning a single infected individual can pass the virus to up to 18 unprotected people. The virus causes systemic immune suppression, making secondary complications highly destructive.

The primary driver of measles-related mortality is pneumonia, which develops in approximately 1 in 20 infected children. Furthermore, acute encephalitis (brain swelling) occurs in roughly 1 per 1,000 cases, carrying a high risk of permanent neurological damage, hearing loss, or intellectual disabilities.

Emergency Mass Vaccination and Treatment Protocols

In a bid to halt active transmission, the government of Bangladesh launched an emergency outbreak response immunization campaign on April 5, 2026, in collaboration with UNICEF, the WHO, and Gavi, the Vaccine Alliance.

Recognizing the extreme vulnerability of infants, the health ministry took the unusual step of lowering the temporary vaccination age, targeting children from 6 months up to 59 months of age. The initial emergency drive successfully covered 1.2 million children across 30 high-burden sub-districts (upazilas) in 18 districts before expanding nationwide. To date, health workers have administered vaccines to more than 18.44 million children, surpassing the initial emergency operational target of 18 million.

[Emergency Clinical Management Protocol]
Clinical Measles Diagnosis ──> Immediate Oral High-Dose Vitamin A
   ├── Children ≥ 12 Months old: 200,000 IU (Repeat on Day 2)
   └── Infants < 12 Months old: 100,000 IU (Repeat on Day 2)

In addition to immunization, clinical management protocols emphasize high-dose vitamin A supplementation for all children diagnosed with clinical measles, regardless of their background nutritional status. Because measles rapidly depletes natural vitamin A reserves—causing depressed retinol levels in up to 92% of hospitalized patients—this therapy is vital to reducing death rates and preventing blindness. For complicated cases exhibiting severe pneumonia or acute diarrhea, a secondary dose is mandatorily administered 24 hours later.

Response Limitations and Global Implications

Despite massive mobilization, severe obstacles remain. A critical shortage of diagnostic reagents and laboratory testing kits has forced the DGHS to classify the vast majority of casualties as “suspected,” leaving a massive gap between verified laboratory numbers and the actual mortality burden on the ground.

The WHO currently rates the national risk for Bangladesh as “high.” Active transmission across multiple divisions, paired with porous borders and dense population centers, raises the threat of cross-border export into neighboring countries within the South-East Asia Region.

For the international public health community, the tragedy in Bangladesh serves as a stark warning regarding post-pandemic upsurges in vaccine-preventable diseases. Because measles requires a strict 95% herd immunity threshold to prevent outbreaks, minor statistical drops in routine vaccination coverage quickly snowball into large-scale humanitarian emergencies.

Medical Disclaimer

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.

References

• https://en.prothomalo.com/bangladesh/qme8wcv96q